source
- Gan & Lee reports positive Phase 3 obesity trial results; J&J shares multiple myeloma dataGan & Lee Pharmaceuticals, a China‑based insulin specialist, announced topline results from its Phase 3 obesity trial, indicating a successful outcome. The company said the study met its primary e…
- European trial registry shows under half of studies missing timely results, analysis saysA new analysis of a major European clinical trial database found that fewer than half of the studies reported results within the legally required timeframe, and only 42% provided complete data. Th…